
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.7B | $3.9B | $3.8B | $3.8B | $3.8B | |
Revenue Growth (YoY) | 11.68% | 6.86% | -3.8% | 0.97% | -0.24% | |
Cost of Revenues | $291.3M | $337.3M | $372.3M | $458.2M | $483.4M | |
Gross Profit | $3.4B | $3.6B | $3.4B | $3.3B | $3.3B | |
Gross Profit Margin | 92.02% | 91.36% | 90.08% | 87.91% | 87.21% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $921.9M | $933.4M | $941.7M | $830.8M | $736.7M | |
Other Inc / (Exp) | -$93M | -$36.7M | $443.7M | $73.5M | $43M | |
Operating Expenses | $2.4B | $2.6B | $3.4B | $2.5B | $2.3B | |
Operating Income | $938M | $930M | $18M | $810.6M | $955.5M | |
Net Interest Expenses | $179M | $197.9M | $203.9M | $228.8M | $254.2M | |
EBT. Incl. Unusual Items | $666M | $695.4M | $257.7M | $655.2M | $744.3M | |
Earnings of Discontinued Ops. | -- | -$2.5M | -$11M | -$736.5K | -- | |
Income Tax Expense | $170.3M | $151.4M | $49.5M | $172.7M | $176.7M | |
Net Income to Company | $666M | $693.3M | $248.1M | $654.5M | $744.3M | |
Minority Interest in Earnings | -$6M | -$6.3M | -$4.6M | -$3.8M | -$4.3M | |
Net Income to Common Excl Extra Items | $489.8M | $535.2M | $192.5M | $478.1M | $563.2M | |
Basic EPS (Cont. Ops) | $2.26 | $2.47 | $0.89 | $2.21 | $2.60 | |
Diluted EPS (Cont. Ops) | $2.26 | $2.47 | $0.89 | $2.21 | $2.60 | |
Weighted Average Basic Share | $216.1M | $216.1M | $216.1M | $216.1M | $216.1M | |
Weighted Average Diluted Share | $216.1M | $216.1M | $216.1M | $216.1M | $216.1M | |
EBITDA | $1.9B | $2B | $2.3B | $2B | $2B | |
EBIT | $867.9M | $904.4M | $469.7M | $900.7M | $1B | |
Revenue (Reported) | $3.7B | $3.9B | $3.8B | $3.8B | $3.8B | |
Operating Income (Reported) | $938M | $930M | $18M | $810.6M | $955.5M | |
Operating Income (Adjusted) | $867.9M | $904.4M | $469.7M | $900.7M | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $992.4M | $963.4M | $954.3M | $967.8M | $951.4M | |
Revenue Growth (YoY) | 15.65% | -2.93% | -0.94% | 1.42% | -1.7% | |
Cost of Revenues | $91.5M | $91.2M | $121.5M | $120.4M | $134.8M | |
Gross Profit | $900.9M | $872.2M | $832.8M | $847.5M | $816.6M | |
Gross Profit Margin | 90.78% | 90.54% | 87.27% | 87.56% | 85.84% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $243.9M | $301.9M | $369.1M | $185.8M | $162.3M | |
Other Inc / (Exp) | -$38.1M | $102.1M | -$28.1M | -$4.7M | $6M | |
Operating Expenses | $657.2M | $694.2M | $581.9M | $551.8M | $548.2M | |
Operating Income | $243.7M | $178M | $250.9M | $295.6M | $268.4M | |
Net Interest Expenses | $46.2M | $49.5M | -- | $55.5M | $71.2M | |
EBT. Incl. Unusual Items | $159.4M | $230.6M | $222.7M | $235.5M | $203.2M | |
Earnings of Discontinued Ops. | -- | -$386.7K | -$455.6K | -- | -- | |
Income Tax Expense | $37.7M | $53.2M | $57.4M | $58.9M | $47.2M | |
Net Income to Company | $159.4M | $230.2M | $222.3M | $235.5M | $203.2M | |
Minority Interest in Earnings | -$1.5M | -$1.5M | -$619.6K | -$1.2M | -$671.2K | |
Net Income to Common Excl Extra Items | $120.2M | $175.5M | $164.3M | $175.3M | $155.3M | |
Basic EPS (Cont. Ops) | $0.55 | $0.81 | $0.76 | $0.81 | $0.72 | |
Diluted EPS (Cont. Ops) | $0.55 | $0.81 | $0.76 | $0.81 | $0.72 | |
Weighted Average Basic Share | $216.1M | $216.1M | $216.4M | $216.1M | $216.1M | |
Weighted Average Diluted Share | $216.1M | $216.1M | $216.4M | $216.1M | $216.1M | |
EBITDA | $477M | $524.6M | $464.9M | $503.9M | $502.2M | |
EBIT | $209.9M | $280.7M | $250.9M | $295.1M | $277.2M | |
Revenue (Reported) | $992.4M | $963.4M | $954.3M | $967.8M | $951.4M | |
Operating Income (Reported) | $243.7M | $178M | $250.9M | $295.6M | $268.4M | |
Operating Income (Adjusted) | $209.9M | $280.7M | $250.9M | $295.1M | $277.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.8B | $3.9B | $3.7B | $3.8B | $3.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $318M | $337M | $401.1M | $457.3M | $497.5M | |
Gross Profit | $3.5B | $3.5B | $3.3B | $3.3B | $3.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.2B | $1.3B | $1.3B | $1.1B | $1B | |
Other Inc / (Exp) | -$185.7M | $4.2M | $225.8M | -$71.1M | -$70.7M | |
Operating Expenses | $2.5B | $2.7B | $3.2B | $2.5B | $2.3B | |
Operating Income | $939.3M | $864.7M | $105.6M | $857M | $930.6M | |
Net Interest Expenses | $93.3M | $102.6M | $54.4M | $116M | $145.4M | |
EBT. Incl. Unusual Items | $660.3M | $766.2M | $277M | $670M | $714.5M | |
Earnings of Discontinued Ops. | -- | -$386.7K | -$10.7M | -$285.4K | -- | |
Income Tax Expense | $160.9M | $166.8M | $59.9M | $174.6M | $165.7M | |
Net Income to Company | $661.6M | $764.1M | $240.2M | $667.7M | $712M | |
Minority Interest in Earnings | -$6.2M | -$6.2M | -$3.9M | -$4.4M | -$3.8M | |
Net Income to Common Excl Extra Items | $493.2M | $590.4M | $202.6M | $490.7M | $545M | |
Basic EPS (Cont. Ops) | $2.28 | $2.73 | $0.93 | $2.27 | $2.52 | |
Diluted EPS (Cont. Ops) | $2.28 | $2.73 | $0.93 | $2.27 | $2.52 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $2B | $2.1B | $1.9B | $1.9B | $1.9B | |
EBIT | $939.7M | $1B | $115.2M | $866M | $943.6M | |
Revenue (Reported) | $3.8B | $3.9B | $3.7B | $3.8B | $3.8B | |
Operating Income (Reported) | $939.3M | $864.7M | $105.6M | $857M | $930.6M | |
Operating Income (Adjusted) | $939.7M | $1B | $115.2M | $866M | $943.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $992.4M | $963.4M | $954.3M | $967.8M | $951.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $91.5M | $91.2M | $121.5M | $120.4M | $134.8M | |
Gross Profit | $900.9M | $872.2M | $832.8M | $847.5M | $816.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $243.9M | $301.9M | $369.1M | $185.8M | $162.3M | |
Other Inc / (Exp) | -$38.1M | $102.1M | -$28.1M | -$4.7M | $6M | |
Operating Expenses | $657.2M | $694.2M | $581.9M | $551.8M | $548.2M | |
Operating Income | $243.7M | $178M | $250.9M | $295.6M | $268.4M | |
Net Interest Expenses | $46.2M | $49.5M | -- | $55.5M | $71.2M | |
EBT. Incl. Unusual Items | $159.4M | $230.6M | $222.7M | $235.5M | $203.2M | |
Earnings of Discontinued Ops. | -- | -$386.7K | -$455.6K | -- | -- | |
Income Tax Expense | $37.7M | $53.2M | $57.4M | $58.9M | $47.2M | |
Net Income to Company | $159.4M | $230.2M | $222.3M | $235.5M | $203.2M | |
Minority Interest in Earnings | -$1.5M | -$1.5M | -$619.6K | -$1.2M | -$671.2K | |
Net Income to Common Excl Extra Items | $120.2M | $175.5M | $164.3M | $175.3M | $155.3M | |
Basic EPS (Cont. Ops) | $0.55 | $0.81 | $0.76 | $0.81 | $0.72 | |
Diluted EPS (Cont. Ops) | $0.55 | $0.81 | $0.76 | $0.81 | $0.72 | |
Weighted Average Basic Share | $216.1M | $216.1M | $216.4M | $216.1M | $216.1M | |
Weighted Average Diluted Share | $216.1M | $216.1M | $216.4M | $216.1M | $216.1M | |
EBITDA | $477M | $524.6M | $464.9M | $503.9M | $502.2M | |
EBIT | $209.9M | $280.7M | $250.9M | $295.1M | $277.2M | |
Revenue (Reported) | $992.4M | $963.4M | $954.3M | $967.8M | $951.4M | |
Operating Income (Reported) | $243.7M | $178M | $250.9M | $295.6M | $268.4M | |
Operating Income (Adjusted) | $209.9M | $280.7M | $250.9M | $295.1M | $277.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $837.8M | $465.3M | $452.7M | $291.8M | $171.5M | |
Short Term Investments | $173.4M | $185.2M | $10.6M | $16.4M | $17M | |
Accounts Receivable, Net | $459.2M | $424.1M | $471.5M | $470.6M | $541.6M | |
Inventory | $85.1M | $71.3M | $64.1M | $60.3M | $56.6M | |
Prepaid Expenses | $221.9M | $247.3M | -- | -- | -- | |
Other Current Assets | $5.3M | $11.2M | $275.9M | $238.4M | $170.9M | |
Total Current Assets | $1.8B | $1.4B | $1.5B | $1.3B | $1.1B | |
Property Plant And Equipment | $5.8B | $6.3B | $5.8B | $5.8B | $6.1B | |
Long-Term Investments | $1.2B | $1.1B | $1B | $987.9M | $982.8M | |
Goodwill | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B | |
Other Intangibles | $82.2M | $22.5M | $28.9M | $25.1M | $26.1M | |
Other Long-Term Assets | $1.4B | $1.8B | $1.5B | $1.4B | $1.1B | |
Total Assets | $12B | $12.2B | $11.2B | $11B | $10.7B | |
Accounts Payable | $1.6B | $1.7B | $1.8B | $1.4B | $1B | |
Accrued Expenses | $1.4B | $1.3B | $1.2B | $1.1B | $1B | |
Current Portion Of Long-Term Debt | $365.8M | $223.5M | $579.9M | $210.1M | $399.9M | |
Current Portion Of Capital Lease Obligations | $84.2M | $88.7M | $188.1M | $106.8M | $125.7M | |
Other Current Liabilities | $219.2M | $208.8M | $91.3M | $105.4M | $66.9M | |
Total Current Liabilities | $4.4B | $4.4B | $4.4B | $3.5B | $3.2B | |
Long-Term Debt | $4.3B | $4.7B | $3.9B | $4.4B | $4.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.5B | $9.7B | $9.2B | $9B | $8.7B | |
Common Stock | $33.4M | $31.2M | $28.8M | $28.9M | $27.5M | |
Other Common Equity Adj | -$741.9M | -$709.2M | -$637.2M | -$761.5M | -$752M | |
Common Equity | $2.4B | $2.4B | $1.9B | $1.9B | $2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $88.6M | $82.7M | $94M | $93.2M | $22.5M | |
Total Equity | $2.5B | $2.5B | $2B | $2B | $2B | |
Total Liabilities and Equity | $12B | $12.2B | $11.2B | $11B | $10.7B | |
Cash and Short Terms | $1B | $650.5M | $463.3M | $308.3M | $188.5M | |
Total Debt | $4.6B | $4.9B | $4.5B | $4.6B | $4.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $648.8M | $495.1M | $480.2M | $250.1M | $239.7M | |
Short Term Investments | $169.5M | $69.7M | $12.1M | $6.7M | $15.7M | |
Accounts Receivable, Net | $455.1M | $465.1M | $452.8M | $500.5M | $546.4M | |
Inventory | $85M | $75.8M | $76.6M | $42.1M | $47.9M | |
Prepaid Expenses | $357M | $282.8M | $280.1M | -- | -- | |
Other Current Assets | $8.6M | $38.7M | $5.8M | $290.3M | $194.3M | |
Total Current Assets | $1.8B | $1.5B | $1.5B | $1.3B | $1.2B | |
Property Plant And Equipment | $6B | $6.3B | $6.1B | $5.9B | $6.2B | |
Long-Term Investments | $1.2B | $1.1B | $1B | $966.5M | $1B | |
Goodwill | $1.3B | $1.2B | $1.2B | -- | $1.1B | |
Other Intangibles | $57.2M | $21.2M | $28.7M | -- | $26.4M | |
Other Long-Term Assets | $1.5B | $1.9B | $1.3B | $1.5B | $1B | |
Total Assets | $12B | $12.2B | $11.4B | $11.1B | $10.9B | |
Accounts Payable | $1.9B | $1.6B | $1.4B | $1.5B | $943.6M | |
Accrued Expenses | $1.4B | $1.3B | $1.2B | $1.6B | $1B | |
Current Portion Of Long-Term Debt | $109.6M | $272.4M | $567.9M | $194.1M | $351.3M | |
Current Portion Of Capital Lease Obligations | $87M | $89.2M | $229.4M | $113.7M | $132.1M | |
Other Current Liabilities | $212.7M | $47.4M | $137M | $32M | $72.7M | |
Total Current Liabilities | $4.5B | $4.4B | $4.6B | $3.7B | $3.3B | |
Long-Term Debt | $4.5B | $4.7B | $4B | $4.3B | $4.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.7B | $9.7B | $9.3B | $9.2B | $8.9B | |
Common Stock | $33M | $30.7M | $29.5M | $28.5M | $27.9M | |
Other Common Equity Adj | -$799M | -$703.1M | -$656.9M | -$752.2M | -$744.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | $151.6M | -- | -- | -- | |
Minority Interest, Total | $87.5M | $81.8M | $95.8M | $21.6M | $23.5M | |
Total Equity | $2.3B | $2.4B | $2B | $1.9B | $2B | |
Total Liabilities and Equity | $12B | $12.2B | $11.4B | $11.1B | $10.9B | |
Cash and Short Terms | $818.3M | $564.8M | $492.2M | $256.8M | $255.5M | |
Total Debt | $4.6B | $4.9B | $4.5B | $4.5B | $4.9B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $666M | $693.3M | $248.1M | $654.5M | $744.3M | |
Depreciation & Amoritzation | $1B | $1.1B | $1.8B | $1.1B | $980.2M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$8.6M | -$76.1M | -$157.5M | $18.9M | -$161.7M | |
Change in Inventories | -$20.5M | $1.2M | $7.5M | $10.7M | $540.4K | |
Cash From Operations | $1.7B | $1.9B | $1.4B | $1.5B | $1.4B | |
Capital Expenditures | $1.6B | $2.1B | $1.8B | $1.4B | $1.2B | |
Cash Acquisitions | -$11.7M | -$28.3M | -$19.4M | -$29.4M | -$65.7M | |
Cash From Investing | -$1.4B | -$2.1B | -$606.1M | -$990.1M | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$337.3M | -$359.5M | -$463.4M | -$419M | -$361.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.4B | $1B | $385.6M | $682.6M | $645M | |
Long-Term Debt Repaid | -$890.4M | -$458M | -$673.7M | -$778.1M | -$494M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$32.1M | -$13.4M | -$3.9M | -$19M | $7.4M | |
Cash From Financing | $9.3M | -$99.5M | -$776.9M | -$708.1M | -$389.3M | |
Beginning Cash (CF) | $491.5M | $816.8M | $439M | $452.9M | $282M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $340.3M | -$336.4M | $16.3M | -$157.6M | -$109.9M | |
Ending Cash (CF) | $811.6M | $485.3M | $463M | $290.6M | $174.5M | |
Levered Free Cash Flow | $140.7M | -$243.7M | -$355.4M | $131.7M | $234.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $187.7M | $179.2M | $222.4M | $184.3M | -- | |
Depreciation & Amoritzation | $287.6M | $529.5M | $218.6M | $212.5M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$7.1M | $121.4M | $140.1M | $65.7M | -- | |
Change in Inventories | -$6.8M | -$2.6M | $22.8M | $5.8M | -- | |
Cash From Operations | $553.9M | $356.1M | $285.6M | $457.2M | -- | |
Capital Expenditures | $731M | $492M | $624.4M | $312.3M | -- | |
Cash Acquisitions | -$17.7M | -$61M | $18.2K | -$50M | -- | |
Cash From Investing | -$759.6M | $132.4M | -$554.4M | -$357.1M | -- | |
Dividends Paid (Ex Special Dividend) | -$180.3M | -$171.4M | -$228.4M | -$173.2M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $312.3M | $110.1M | $403.5M | $170.3M | -- | |
Long-Term Debt Repaid | -$49M | -$140.4M | -$124.3M | -$103.5M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.7M | $2.5M | $5.2M | $15.2M | -- | |
Cash From Financing | $32.5M | -$246.2M | $88.5M | -$136.8M | -- | |
Beginning Cash (CF) | $651.9M | $497.9M | $475.4M | $250.9M | -- | |
Foreign Exchange Rate Adjustment | -$15.5K | $5.2M | $2.2M | $1.8M | -- | |
Additions / Reductions | -$173.1M | $242.4M | -$180.3M | -$36.7M | -- | |
Ending Cash (CF) | $481.2M | $736M | $290.8M | $206.7M | -- | |
Levered Free Cash Flow | -$177.1M | -$135.9M | -$338.8M | $145M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $661.6M | $764.1M | $240.2M | $667.7M | $712M | |
Depreciation & Amoritzation | $1.1B | $1.1B | $1.8B | $1B | $996.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $18.8M | -$110.9M | -$254.9M | $131.2M | -$162M | |
Change in Inventories | -$37.3M | $11M | -$6.6M | $37.3M | -$7.1M | |
Cash From Operations | $1.7B | $1.9B | $1.5B | $1.5B | $1.4B | |
Capital Expenditures | $1.7B | $2.1B | $1.7B | $1.4B | $1.1B | |
Cash Acquisitions | -$22.2M | -$18.8M | -$19.7M | -$29.5M | -$64.4M | |
Cash From Investing | -$1.4B | -$2.1B | -$438.8M | -$1B | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$337.4M | -$359.3M | -$463.6M | -$418.7M | -$362.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.4B | $970.9M | $266.3M | $702.9M | $687.5M | |
Long-Term Debt Repaid | -$1.1B | -$291.7M | -$613.8M | -$822.5M | -$506.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$32.7M | -$11.1M | -$25.4M | -$79.8M | $92M | |
Cash From Financing | -$288.5M | $150.2M | -$1.1B | -$717.7M | -$285.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $27.9M | -$118.4M | $4.8M | -$243.6M | $17.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $84.3M | -$270.3M | -$183.4M | $127.4M | $289.5M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $347M | $409.4M | $444.6M | $419.8M | $203.2M | |
Depreciation & Amoritzation | $554.6M | $773.4M | $432.6M | $421.3M | $225M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$34.4M | $59.4M | -$19.3M | $18.6M | -$47.4M | |
Change in Inventories | -$11.8M | $2.2M | $13.4M | $23M | $9.6M | |
Cash From Operations | $916.5M | $714.7M | $771M | $881.4M | $422.4M | |
Capital Expenditures | $1.1B | $928.8M | $1B | $647M | $277.8M | |
Cash Acquisitions | -$28.2M | -$61.9M | -$1.3M | -$51.4M | -$137.7K | |
Cash From Investing | -$1.2B | -$317.8M | -$837.4M | -$655.3M | -$272.8M | |
Dividends Paid (Ex Special Dividend) | -$180.8M | -$171.7M | -$228.9M | -$173.3M | -$671.2K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $560.8M | $284.1M | $458.2M | $245.3M | $117.4M | |
Long-Term Debt Repaid | -$371.2M | -$296.2M | -$220.2M | -$243.8M | -$152.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9.6M | -$246.2K | -$19M | -$69.8M | -$447.5K | |
Cash From Financing | -$90.5M | -$119.4M | -$90.4M | -$325.4M | -$84.6M | |
Beginning Cash (CF) | $1.5B | $958.7M | $934.9M | $539.6M | $172.3M | |
Foreign Exchange Rate Adjustment | $1.7M | $7.3M | -$5.3M | $26.5M | -$481.9K | |
Additions / Reductions | -$356.2M | $277.4M | -$156.9M | -$99.3M | $65M | |
Ending Cash (CF) | $1.1B | $1.2B | $766.2M | $457.6M | $236.8M | |
Levered Free Cash Flow | -$228.8M | -$214.2M | -$245.1M | $234.4M | $144.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.